Makowka L, Falk R E, Falk J A, Teodorczyk-Injeyan J, Venturi D, Rotstein L E, Falk W, Langer B, Blendis L M, Phillips M J
Cancer. 1983 Jun 15;51(12):2181-90. doi: 10.1002/1097-0142(19830615)51:12<2181::aid-cncr2820511206>3.0.co;2-u.
This report further evaluates the concept that the interaction of factors that originate within the liver can contribute, regulate or even initiate the actual development of hepatic regeneration after liver cell necrosis or partial hepatectomy. The effect of liver cytosol (100,000 g supernatant), both from intact adult rat liver (NLC) and from adult rat liver remnants that had been regenerating for 24 hours after 70% partial hepatectomy (PH) in posthepatectomy liver regeneration in the rat was studied. The specificity of the growth-controlling properties in liver cytosol was determined using tumor cells. The intraperitoneal administration of NLC after PH resulted in approximately 70-80% inhibition of the peak 3H-DNA specific activity seen in controls at 18 and 24 hours post-PH, with a significant increase in DNA synthesis at 31-40 hours post-PH. The intraperitoneal administration of RLC after PH, augmented the hepatic regenerative response normally produced. Autoradiographic determination of hepatic nuclear labeling confirmed the inhibitory and stimulatory properties of NLC and RLC respectively. Syngeneic NLC or RLC at six and 24 days after subcutaneous tumor inoculation resulted in significant inhibition of tumor growth for both a methylcholanthrene-induced bladder carcinoma (FBCa) and an HTC-hepatoma. The retardation of FBCa growth could be enhanced by administering NLC or RLC every three or seven days. Syngeneic and xenogeneic liver cytosol resulted in dose-dependent inhibition of P815 mastocytoma cell proliferation in vitro. It is apparent from these studies that both stimulatory and inhibitory factors can be extracted from liver tissue that not only influence liver cell regeneration, but also affect tumor growth. Further isolation and characterization of these factors may lead to an understanding of more fundamental problems such as the control of normal and malignant cell growth.
本报告进一步评估了一种观点,即源自肝脏内部的多种因素相互作用,可能在肝细胞坏死或部分肝切除术后,对肝再生的实际进程产生作用、进行调节甚至启动这一进程。研究了来自成年大鼠完整肝脏的肝胞质溶胶(100,000g 上清液)(NLC)以及在 70%部分肝切除(PH)后已再生 24 小时的成年大鼠肝残余组织的肝胞质溶胶(RLC)对大鼠肝切除术后肝再生的影响。利用肿瘤细胞确定了肝胞质溶胶中生长控制特性的特异性。在 PH 后腹腔注射 NLC,导致 PH 后 18 小时和 24 小时对照组中观察到的 3H-DNA 比活性峰值受到约 70 - 80%的抑制,而在 PH 后 31 - 40 小时 DNA 合成显著增加。PH 后腹腔注射 RLC,则增强了正常产生的肝再生反应。肝细胞核标记的放射自显影测定分别证实了 NLC 和 RLC 的抑制和刺激特性。在皮下接种肿瘤后第 6 天和第 24 天,同基因的 NLC 或 RLC 对甲基胆蒽诱导的膀胱癌(FBCa)和 HTC - 肝癌均导致肿瘤生长显著受抑。每三天或七天给予 NLC 或 RLC 可增强对 FBCa 生长的抑制作用。同基因和异基因肝胞质溶胶在体外导致 P815 肥大细胞瘤细胞增殖呈剂量依赖性抑制。从这些研究中可以明显看出,刺激和抑制因子均可从肝组织中提取,它们不仅影响肝细胞再生,还影响肿瘤生长。对这些因子的进一步分离和特性鉴定可能有助于理解更基本的问题,如正常和恶性细胞生长的控制。